|
|
||||||||
J Thorac Cardiovasc Surg 1999;118:961-963
© 1999 Mosby, Inc.
BRIEF COMMUNICATIONS |
From the Divisions of Cardiology,a Cardiothoracic Surgery,b and Anesthesiology,c and the Departments of Pediatrics, Surgery, and Critical Care Medicine, The Childrens Hospital of Philadelphia and The University of Pennsylvania School of Medicine, Philadelphia, Pa
*Current address: Cardiac Surgical Unit, Melbourne Royal Childrens Hospital, Victoria, Australia.
Address for reprints: Mitchell I. Cohen, MD, Division of Pediatric Cardiology, The Childrens Hospital of Philadelphia, 34th and Civic Center Blvd, Philadelphia, PA 19104 (E-mail:Internet:cohenmi{at}mail.chop.edu).
Extracorporeal membrane oxygenation (ECMO) provides mechanical cardiopulmonary support and has been used for children with severe respiratory failure, intractable heart failure, sepsis, pulmonary hypertension, and as a bridge to heart transplantation.
1-5 The use of ECMO has not been reported in children with structurally normal hearts and medically refractory polymorphic ventricular tachycardia (VT) and ventricular fibrillation (VF).
Clinical summaries
Patient 1.
A 3
-year-old (15 kg) girl was well until the day of admission, when she was found pale and pulseless on the floor. A neighbor quickly initiated cardiopulmonary resuscitation (CPR), and within 5 minutes an emergency medical team arrived. The initial rhythm strip revealed VF. She was intubated, defibrillated, and transported to Childrens Hospital of Philadelphia. CPR was continued throughout the transport. On arrival in the emergency department she was asystolic and received 150 µg of epinephrine and defibrillation with 30 J. The rhythm after attempted cardioversion was polymorphic VT. She subsequently received multiple doses of lidocaine, bretylium, magnesium, calcium, bicarbonate, and asynchronous cardioversion leading to brief periods of a perfusing rhythm, only to be followed by polymorphic VT and VF(Fig 1). There were no electrolyte abnormalities. The chest radiograph showed a normal heart size and an echocardiogram during a brief period of sinus rhythm revealed good biventricular function. The initial arterial blood gas examination revealed a pH of 6.95, PaCO2 49 mm Hg, PaO2 60 mm Hg, and a base deficit of 20. Her head was packed in ice for the entire resuscitation. Because of the recalcitrant nature of the arrhythmia, the right carotid artery and right internal jugular vein were cannulated and she was supported with venoarterial ECMO with resolution of the VT/VF. The estimated time of CPR was 50 minutes. The patient was transferred to the cardiac intensive care unit while being supported by ECMO (flow: 65 mL · kg1 · min1 at 37°C) in addition to infusions of lidocaine and esmolol. An echocardiogram 2 hours after the cardiac arrest revealed markedly depressed left ventricular function, consistent with myocardial stunning. Left ventricular function recovered to normal levels, and she was weaned from ECMO and decannulated 48 hours later. The electrocardiogram was consistent with long QT syndrome (QTc interval 480 ms and abnormal T waves). A magnetic resonance imaging scan showed no evidence of right ventricular dysplasia. Cardiac catheterization revealed a cardiac index of 3.5 L · min1 · m2 and angiography revealed normal coronary arteries. The patient underwent placement of a transvenous automatic internal cardioverter defibrillator (VENTAK MINI IV, Guidant, St Paul, Minn). She continued to have nonsustained VT controlled with a combination of mexiletine and nadolol. The patient had no end-organ damage and was evaluated by a pediatric neurologist who found no focal deficits. She was discharged home 26 days after her initial admission.
|
Discussion.
VT in children is rare, typically associated with congenital heart defects after reparative or palliative operations. Successful management of VT is usually achieved with antiarrhythmic drugs such as lidocaine, esmolol, bretylium, procainamide, or amiodarone, as well as correction of any electrolyte abnormality. Overdrive ventricular pacing can be used for VT at slower rates. VF is even less common and is one of the presumed terminal events causing sudden death in children and young adults.
VF results in ineffective perfusion of the myocardium and requires immediate defibrillation as well as the initiation of CPR. Despite antiarrhythmic treatment and multiple attempts at cardioversion, both of our patients continued to have intractable polymorphic VT degenerating into VF. Ongoing VF results in elevated end-diastolic pressures, limiting the ability to maintain myocardial perfusion during increased myocardial oxygen consumption. Prolonged VT/VF may lead to subendocardial ischemia and ventricular dysfunction. By providing biventricular support, venoarterial ECMO decompressed the heart, reduced myocardial work, and enabled standard medical therapy to terminate the arrhythmia. Both patients had significant myocardial dysfunction, which resolved during venoarterial ECMO support. Venoarterial ECMO provides adequate cardiac output during the period of ventricular dysfunction without the need for inotropic agents that may be proarrhythmic.
A critical factor in the successful resuscitation of patients who have had a cardiac arrest is the prompt establishment of an adequate cardiac output. CPR and ECMO should be considered in venues other than the cardiac intensive care unit (ie, emergency department) for patients with a witnessed cardiac arrest (known "down-time") who do not respond to medical management. Because of inherent delays in initiating ECMO (ie, time, priming the pump, and personnel), consideration for mechanical support should be given early if conventional medical strategies fail to control the arrhythmia. The rapid deployment of ECMO for medically refractory polymorphic VT and VF led to a successful outcome for these 2 patients.
References
This article has been cited by other articles:
![]() |
P. S. Pagel, R. E. Lilly, and A. C. Nicolosi Use of ECMO to temporize circulatory instability during severe Brugada electrical storm. Ann. Thorac. Surg., September 1, 2009; 88(3): 982 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Mahle, J. M. Forbess, P. M. Kirshbom, A. R. Cuadrado, J. M. Simsic, and K. R. Kanter Cost-utility analysis of salvage cardiac extracorporeal membrane oxygenation in children J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1084 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Doll, B. Kiaii, M. Borger, J. Bucerius, K. Kramer, D. V. Schmitt, T. Walther, and F. W. Mohr Five-Year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock Ann. Thorac. Surg., January 1, 2004; 77(1): 151 - 157. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |